Randomized Placebo-Controlled Study of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High Risk, HR+, HER2 Neg, Breast Cancer (S1207)

Randomized Placebo-Controlled Study of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High Risk, HR+, HER2 Neg, Breast Cancer (S1207)

Trial Category:
Breast
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members